Farag Kameel D.
Reporting owner on Forms 3, 4 and 5, CIK 2093620.
Farag Kameel D. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AKTX · Akari Therapeutics PlcCIK 1541157 | officer (Interim CFO) | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-11-17 | A granted | +1,284 | $10.12 | 24,593 | Form 4 |
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-11-17 | A granted | +1,589 | $8.18 | 26,182 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001493152-26-053314 | Akari Therapeutics Plc | 2026-11-19 |